(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.69% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Avient's revenue in 2025 is $3,238,000,000.On average, 5 Wall Street analysts forecast AVNT's revenue for 2025 to be $299,879,036,324, with the lowest AVNT revenue forecast at $297,719,321,819, and the highest AVNT revenue forecast at $302,570,555,926. On average, 5 Wall Street analysts forecast AVNT's revenue for 2026 to be $312,514,304,388, with the lowest AVNT revenue forecast at $309,655,188,377, and the highest AVNT revenue forecast at $316,492,682,486.
In 2027, AVNT is forecast to generate $325,235,613,207 in revenue, with the lowest revenue forecast at $318,625,394,839 and the highest revenue forecast at $330,422,131,664.